QUINCE THERAPEUTICS INC

Quince Therapeutics, Inc. is a biotechnology company whose core business model involves the use of animals in research and development. The company’s primary activities center on discovering and developing therapeutic candidates, a process that inherently relies on animal testing for preclinical efficacy and safety studies. This commercial exploitation of animals is a foundational component of the biopharmaceutical industry and of Quince’s operations.

The company’s public filings and regulatory disclosures consistently reference compliance with animal welfare laws as a material risk factor, indicating that animal use is an integral and legally acknowledged part of its business. While specific incident reports or enforcement actions were not detailed in the gathered evidence, the structural reliance on animal models places the company within the broad category of commercial animal exploitation. This exclusion is applied as a catch-all for such business models where animal use is central to the product development pipeline, absent a more specific code for animal testing in the therapeutic context.